International Consortium on Anti-Virals / Consortium International sur les Thérapies Antivirales

En FrançaisRead Our BlogContactHome

 

Follow ICAV-CITAV on Twitter

May 2007 - Nigeria Meeting

Speakers

 

Dr. Oyewal Tomori, Redeemer’s University
“Viral Diseases in Control of Africa”

Dr. Jeremy Carver – “The ICAV Vision”;
“The ICAV anti-viral platform”

Dr. Abdulsalami Nasidi, Federal Ministry of Health,
“The First Human Case of H5N1 Infection in Sub-Saharan Africa”

Dr. Oyekanmi Nash,
“ICAV Africa”

Dr. Daniel F. Adene, University of Ibadan,
“The Baseline in Nigeria’s Avian Influenza and the Pro-Pandemic Epidemiologic Links I Developing Agro-Ecology”

Dr. Claude Miller, Institute of Virology, Luxembourg:
“The spread and evolution of highly pathogenic Avian Influenza (HPAI) H5N1 in Africa”

Dr. Gavin Smith, University of Hong Kong:
"Evolution of H5N1 Avian Influenza: Evidence from the Fields"

Dr. A.A. Owoade, Department of Veterinary Medicine, University of Ibadan,
“Multiple introductions of H5N1 in Nigeria”

Dr. Abdul Habib, Institute of Human Virolgy-Nigeria, Abuja
“ Recognition and Prevention of Avian Influenza in Human”

Dr. James Shepherd, Institute of Human Virolgy-Nigeria, Abuja
“Clinical Management of Avian Influenza in Humans”

Dr. Eleanor Fish
“Wide-spectrum Anti-Virals: Interferon”

Dr. Rolf Hilgenfeld, University of Lϋbeck
“Virtual screening and docking of new inhibitors for neuraminidase”

Dr. Michel Chrétien, Ontario Health Research Institute, University of Ottawa, Canada
‘Convertases’

Dr. Ruben Donis, CDC-Atlanta
“The Origin of the Current H5N1 Outbreaks”

Dr. Xiu-Feng (Henry) Wan, Miami University, Oxford, OH
“A Robust and Quantitative Genotype Algorithm Reflecting H5N1 AI Niches”

Dr. Sunday Omilabu, Central Research Laboratory, Lagos University Teaching Hospital
“Lassa Fever In Nigeria”

Mr. Babatunde Bello, Federal Ministry of Information
“Nigerian Communication Strategies for Avian and Pandemic Influenza”